Do countries have the capacity to diagnose XDR cases in time?
The TB Research Centre (TRC) in Chennai, India, and the national reference laboratory in Bangkok Thailand are part of the WHO Supra-National Reference Laboratory Network, and have the capability to perform DST for second-line drugs. There are other laboratories that are undertaking such tests. However no others are recognized by WHO for such tests in the Region. WHO is currently working with the Indian TB Programme and TRC to develop and implement plans for enhancing the capacity of laboratories in India for second line anti-TB drug susceptibility testing. National TB control programme will need increased funding and human resources to rapidly scale-up laboratories and address drug resistant TB.